Skip to main content

Akso Health Group

corporate_fare Company Profile

Akso Health Group

AHG·NASDAQ·Trade & Services·CIK 0001702318

Akso Health Group operates as a healthcare equipment and product trading company and provides related healthcare services. Historically, the company generated revenue from loan facilitation and related services, but disposed of this P2P Business on December 30, 2020. It then transitioned to a social e-commerce platform operator in China, which it disposed of in May 2023. Since the fourth quarter of 2021, Akso Health Group has explored the healthcare sector. On January 4, 2022, it incorporated Akso Online Meditech in Wyoming, which sells COVID-19 Rapid Antigen test kits. In February 2022, Akso Online Meditech entered a supply agreement to purchase "iHealth" branded COVID-19 Rapid Antigen test kits and sells these to distributors in the United States. On January 26, 2022, the company incorporated Qingdao Akso in Shandong Province, China, and began selling medical devices through it in April 2022. Qingdao Akso purchases medical devices such as defibrillators and anesthesia laryngoscopes from suppliers and sells them to distributors or end-users in China. The company has advanced its presence in online hospital and chain pharmacy segments in China. In November 2024, Akso Health Group acquired Tianjin Wangyi Cloud Co., Ltd. and its wholly owned subsidiaries, Tianjin Deyihui Online Hospital Co., Limited and Tianjin Deyihui Clinic Co., Limited (collectively "Deyihui Group"), to strengthen its internet healthcare presence. The company evaluates potential acquisitions of online hospitals in certain Chinese cities that provide online medical consultations for initial diagnosis, follow-up consultations, and chronic disease management.

Akso Health Group (NASDAQ:AHG) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 2 items for AHG at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-23, rated 9/10. Across its 2 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for AHG spans 20-F, 6-K.

Recent high-impact activity:

  • Akso Health Group 20-F: Going Concern Warning, $18.7M Loss, and Remediated Controls
  • Akso Health Reports Significant Cash Burn and Widened Net Loss Amidst Major Internet Hospital Investment

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
13.83M
Net Income
-18.67M
Diluted EPS
0.01
Op. Cash Flow
-12.79M
Free Cash Flow
-12.79M
Gross Profit
-11.31K
Operating Income
-20.7M
Cash & Equivalents
170.57K
Debt / Equity
0.00×
Net Margin
-135.0%
Shares Outstanding
2.17B sh
Source: 20-F · filed 2026-07-23 · accession 0001213900-26-080868

Short Interest & Short Volume

1.02 days to cover

FINRA reported short interest of 19,943 shares in AHG as of the September 15, 2026 settlement, a 1.9% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 40.3% of AHG volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)19,943 shares as of September 15, 2026
Change vs prior period▲ 1.9%
Days to cover1.02 at avg daily volume of 19,601
Daily short volume (FINRA facilities)40.3% of 33,012 shares on October 2, 2026
5-day average short volume55.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

AHG files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with A →
$1.08 -0.07% today
52-week range · as of 2026-07-23 $1.08 – $2.5
Market cap
$985.21M
Volume
82.4K (0.4× avg)
3-mo avg 211.6K
Live data · 2026-10-03 15:11 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AHG - Latest Insights

AHG
Jul 23, 2026, 4:05 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $1.47
Real-time Price: $1.08 info
Change: -$0.390 (-27%) info
Market Cap: $985.21M info
AHG
Feb 10, 2026, 4:06 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.45
Real-time Price: $1.08 info
Change: -$0.365 (-25%) info
Market Cap: $985.21M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets